妊娠早期中期的胎儿生长受限与不良围产结局
该回顾性队列研究纳入2010至2014年单中心12,783例孕17至22周超声评估胎儿解剖的单胎无畸形妊娠,比较有无胎儿生长受限者的围产结局。早期中期胎儿生长受限发生率为2.8%,与出生小于胎龄儿、死产、新生儿死亡及指征性早产风险升高相关。
要点
- 孕17至22周孤立性胎儿生长受限发生率为2.8%(355/12,783)。
- 早期中期生长受限与出生小于胎龄儿风险升高相关(36.9% vs 9.1%,校正OR 5.5,95%CI 4.3-7.0)。
- 死产(2.5% vs 0.4%,OR 6.2,95%CI 2.7-12.8)和新生儿死亡(1.4% vs 0.3%,OR 5.2,95%CI 1.6-13.5)风险亦升高。
核心结论
- 早期中期胎儿生长受限虽发生率低于3%且多数孤立性生长受限者无不良结局,但为出生小于胎龄儿、死产、新生儿死亡及指征性早产的强烈危险因素。
研究设计与样本
- 2010至2014年单中心回顾性队列研究,纳入孕17至22周行胎儿解剖超声评估的单胎无畸形妊娠,排除胎儿结构畸形、染色体异常或已明确感染病因者,最终分析12,783例。
主要发现
- 早期中期胎儿生长受限者355例(2.8%),危险因素包括非裔美国人种族和吸烟。
- 生长受限组出生小于胎龄儿发生率为36.9%,无生长受限组为9.1%(校正OR 5.5,95%CI 4.3-7.0)。
- 生长受限组死产发生率为2.5%,无生长受限组为0.4%(OR 6.2,95%CI 2.7-12.8)。
- 生长受限组新生儿死亡发生率为1.4%,无生长受限组为0.3%(OR 5.2,95%CI 1.6-13.5)。
- 生长受限组指征性早产小于37周发生率为7.3%,无生长受限组为3.3%(OR 2.3,95%CI 1.5-3.5);小于28周发生率为2.5% vs 0.2%(OR 10.8,95%CI 4.5-23.4)。
关键数值与推荐
- 胎儿生长受限定义为估测胎儿体重小于同孕龄第10百分位。
- 主要结局为出生小于胎龄儿,定义为出生体重小于第10百分位。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To estimate the risk of adverse perinatal outcomes among women with isolated fetal growth restriction from 17 to 22 weeks of gestation. METHODS: This was a retrospective cohort study of all singleton, nonanomalous pregnancies undergoing ultrasonography to assess fetal anatomy between 17 and 22 weeks of gestation at a single center from 2010 to 2014. After excluding patients with fetal structural malformations, chromosomal abnormalities, or identified infectious etiologies, we compared perinatal outcomes between pregnancies with and without fetal growth restriction, defined as estimated fetal weight less than the 10th percentile for gestational age. Our primary outcome was small for gestational age (SGA) at birth, defined as birth weight less than the 10th percentile. Secondary outcomes included preterm delivery at less than 37 and less than 28 weeks of gestation, preeclampsia, abruption, stillbirth, neonatal death, neonatal intensive care unit admission, intraventricular hemorrhage, need for respiratory support, and necrotizing enterocolitis. RESULTS: Of 12,783 eligible patients, 355 (2.8%) had early second-trimester fetal growth restriction. Risk factors for growth restriction were African American race and tobacco use. Early second-trimester growth restriction was associated with a more than fivefold increase in risk of SGA at birth (36.9% compared with 9.1%, adjusted odds ratio [OR] 5.5, 95% CI 4.3-7.0), stillbirth (2.5% compared with 0.4%, OR 6.2, 95% CI 2.7-12.8), and neonatal death (1.4% compared with 0.3%, OR 5.2, 95% CI 1.6-13.5). Rates of indicated preterm birth at less than 37 weeks of gestation (7.3% compared with 3.3%, OR 2.3, 95% CI 1.5-3.5) and less than 28 weeks of gestation (2.5% compared with 0.2%, OR 10.8, 95% CI 4.5-23.4), neonatal need for respiratory support (16.9% compared with 7.8%, adjusted OR 1.6, 95% CI 1.1-2.2), and necrotizing enterocolitis (1.4% compared with 0.2%, OR 7.7, 95% CI 2.3-20.9) were also significantly higher for those with growth restriction. Rates of preeclampsia, abruption, and other neonatal outcomes were not significantly different. CONCLUSION: Although fetal growth restriction in the early second trimester occurred in less than 3% of our cohort and most of those with isolated growth restriction did not have adverse outcomes, it is a strong risk factor for SGA, stillbirth, neonatal death, and indicated preterm birth.
引用
- Temming LA, Dicke JM, Stout MJ, et al. Early Second-Trimester Fetal Growth Restriction and Adverse Perinatal Outcomes. Obstet Gynecol. 2017. PMID: 28885423. doi:10.1097/AOG.0000000000002209
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。